Single-ascending Dose Study With a Food-Effect Cohort to Evaluate AMG 581

Clinical trial NCT02567370 · COMPLETED

Trial details

NCT number: NCT02567370
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Schizophrenia or Schizoaffective Disorder

Start date: 2015-08-01
Primary completion: 2015-10-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.